1. Dadonaite B. Antiretroviral therapy has saved millions of lives from AIDS and could save more. Our World In Data. 2019. https://ourworldindata.org/art-lives-saved. Accessed 28 March 2020.
2. Joint United Nations Programme on HIV and AIDS. UNAIDS 2019 Data. UNAIDS. 2019. https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf. Accessed 28 March 2020.
3. Joint United Nations Programme on HIV and AIDS. Understanding Fast Track: Accelerating Action to End the AIDS Epidemic by 2030. UNAIDS. 2015. https://www.unaids.org/sites/default/files/media_asset/201506_JC2743_Understanding_FastTrack_en.pdf. Accessed 28 March 2020.
4. Kurth AE, Celum C, Baeten JM, Vermund, SH, Wasserheit, JN. Combination HIV Prevention:
Significance, Challenges, and Opportunities. Current HIV/AIDS Reports. 2011 2011/03/01;8(1):62-72.
5. Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O'Reilly KR, Koechlin FM, et al. Effectiveness
and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973-1983.
6. AVAC: Country updates PrEPWatch. https://www.prepwatch.org/in-practice/country-updates/. Accessed 3 Oct 2019.
7. Hodges-Mameletzis I, Dalal S, Msimanga-Radebe B, Rodolph M, Baggaley R. Going global: the adoption of the World Health Organization's enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex Health. 2018 Nov;15(6):489-500.
8. Hayes R, Schmidt AJ, Pharris A, Azad Y, Brown AE, Weatherburn P, et al. Estimating the ‘PrEP Gap’: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019. Euro Surveill. 2019;24(41):pii=1900598.
9. World Health Organization. Implementation Tool for Pre-Exposure Prophylaxis of HIV infection. WHO. 2017. https://www.who.int/hiv/pub/prep/prep-implementation-tool/en/. Accessed 3 Oct 2019.
10. Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, Mayer KH, Mimiaga M, Patel R, et al. Defining
the HIV pre-exposure prophylaxis care continuum. AIDS. 2017 Mar 13;31(5):731-734.
11. Liu AY, Colfax G, Cohen S, Bacon O, Kolber MA, Amico KR. The Spectrum of engagement in
HIV prevention: Proposal for a PrEP cascade. 7th International Conference on HIV Treatment and
Prevention Adherence; Miami. 2012.
12. Nwokolo N, Hill A, McOwan A, Pozniak A. Rapidly declining HIV infection in MSM in central London. Lancet HIV. 2017 Nov;4(11):e482-e483.
13. Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, et al. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services. JAMA Intern Med. 2016 Jan;176(1):75-84.
14. Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5(11):e629-e637.
15. Marcus JL, Paltiel AD, Walensky RP. Has Pre-exposure Prophylaxis Made a Difference at a
Population Level? Jury Is Still Out. Clinical Infectious Diseases. 2020.
16. Venter WDF. Pre-exposure Prophylaxis: The Delivery Challenge. Front Public Health. 2018;6:188.
17. Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP Implementation Through Multilevel Interventions: A Synthesis of the Literature. AIDS Behav. 2018 Nov;22(11):3681-3691.
18. Pleuhs B, Quinn KG, Walsh JL, Petroll AE, John SA. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review. AIDS Patient Care and STDs. 2020.
19. Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the methodology. Implementation Science. 2010;5(1):69.
20. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology. 2005;8(1):19-32.
21. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Annals of Internal Medicine. 2018;169(7):467-473.
22. Liu AY, Cohen S, Follansbee S, Cohan D, Weber S, Sachdev D, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014 Mar;11(3):e1001613.
23. Vuylsteke B, Reyniers T, Lucet C, Nöstlinger C, Deblonde J, Libois, A, et al. High uptake of pre-exposure prophylaxis (PrEP) during early roll-out in Belgium: results from surveillance reports. Sex Health. 2019 Feb;16(1):80-83.
24. Girometti N, McCormack S, Devitt E, Gedela K, Nwokolo N, Patel S, et al. Evolution of a pre-exposure prophylaxis (PrEP) service in a community-located sexual health clinic: concise report of the PrEPxpress. Sex Health. 2018 Nov;15(6):598-600.
25. National AIDS and STI Control Program (NASCOP) Ministry of Health. Framework for the Implementation of Pre-Exposure Prophylaxis of HIV In Kenya. 2017:1-84.
26. Tung EL, Thomas A, Eichner A, Shalit P. Implementation of a community pharmacy-based pre-
exposure prophylaxis service a novel model for pre-exposure prophylaxis care. Sex Health.
27. Health Protection Scotland and Information Services Division. Implementation of HIV PrEP in Scotland. 2019:1-60.
28. Ministry of Health and Child Care. Implementation Plan for HIV Pre-Exposure Prophylaxis In
Zimbabwe 2018-2020. 2018:1-60.
29. Saxton PJ, Giola M, Coughland EP, Rich JG, Azariah S, Ludlam AH, et al. Implementing HIV pre-
exposure prophylaxis (PrEP): Let's not get caught with our pants down. N Z Med J. 2018;131(1481):64-73.
30. Hoth AB, Shafer C, Dillon D, Mayer R, Walton G, Ohl M. Iowa TelePrEP: A Public-Health-Partnered Telehealth Model for Human Immunodeficiency Virus Preexposure Prophylaxis Delivery in a Rural State. Sex Transm Dis. 2019;46(8):507-512.
31. Schmidt HA, McIver R, Houghton R, Selvey C, McNulty A, Varma R, et al. Nurse-led pre-
exposure prophylaxis: a non-traditional model to provide HIV prevention in a resource-constrained,
pragmatic clinical trial. Sex Health. 2018 Nov;15(6):595-597.
32. Masyuko S, Mukui I, Njathi O, Kimani M, Oluoch P, Wamicwe J, et al. Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study. Sex Health. 2018 Nov;15(6):578-586.
33. Bien CH, Patel VV, Blackstock OJ, Felsen UR. Reaching Key Populations: PrEP Uptake in an
Urban Health Care System in the Bronx, New York. AIDS Behav. 2017 May;21(5):1309-1314.
34. Kamis KF, Marx GE, Scott KA, Gardner E M, Wendel KA, Scott ML, et al. Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care. Open Forum Infect Dis. 2019 Jul;6(7):ofz310.
35. Marcus JL, Volk JE, Pinder J, Liu AY, Bacon O, Hare CB, et al. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings. Curr HIV/AIDS Rep. 2016 Apr;13(2):116-24.
36. Eccles-Radtke C, Henry K. Turning the Tide against AIDS by Preventing New HIV Infections: Initial Experience with Minnesota’s First PrEP Clinic. Minn Med. 2015;98(1):45-48.
37. South Africa Department of Health. Guidelines for Expanding Combination Prevention and Treatment Options: Oral Pre-Exposure Prophylaxis (PrEP) and Test and Treat (T&T). 2016: 1-29.
38. O'Byrne P, MacPherson P, Orser L, Jacob JD, Holmes D. PrEP-RN: Clinical Considerations and Protocols for Nurse-Led PrEP. J Assoc Nurses AIDS Care. 2019;30(3):301-311.
39. Finkenflugel RNN, Hoornenborg E, Achterbergh RCA, Marra E, Davidovich U, de Vries HJC, et
al. A Mobile Application to Collect Daily Data on Preexposure Prophylaxis Adherence and Sexual
Behavior Among Men Who Have Sex With Men: Use Over Time and Comparability With Conventional
Data Collection. Sex Transm Dis. 2019 Jun;46(6):400-406.
40. Sharma M, Chris A, Chan A, Knox DC, Wilton J, McEwen O, et al. Decentralizing the delivery of
HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a
dissemination and implementation study protocol. BMC Health Serv Res. 2018 Jul 3;18(1):513.
41. Siegler AJ, Mayer KH, Liu AY, Patel RR, Ahlschlager LM, Kraft CS, et al. Developing and Assessing the Feasibility of a Home-based Preexposure Prophylaxis Monitoring and Support Program. Clin Infect Dis. 2019 Jan 18;68(3):501-504.
42. Refugio ON, Kimble MM, Silva CL, Lykens JE, Bannister C, Klausner JD. PrEPTECH: A Telehealth-Based Initiation Program for HIV Pre-exposure Prophylaxis in Young Men of Color Who Have Sex With Men. A Pilot Study of Feasibility. J Acquir Immune Defic Syndr. 2019;80(1):40-45.
43. Walmsley B, Gallant D, Naccarato M, Hull M, Smith A, Tan DH. The PrEP You Want: A Web-Based Survey of Online Cross-Border Shopping for HIV Prophylaxis Medications. J Med Internet Res. 2019 Jul 22;21(7):e12076.
44. Liu AY, Vittinghoff E, von Felten P, Rivet AK, Anderson PL, Lester R, et al. Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study. Clin Infect Dis. 2019 May 30;68(12):2010-2017.
45. Fuchs JD, Stojanovski K, Vittinghoff E, McMahan VM, Hosek SG, Amico KR, et al. A Mobile
Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis. AIDS Patient Care STDS.
46. Brown W 3rd, Giguere R, Sheinfil A, Ibitoye M, Balan I, Ho T, et al. Challenges and solutions
implementing an SMS text message-based survey CASI and adherence reminders in an international
biomedical HIV PrEP study (MTN 017). J Biomed Inform. 2018 Apr;80:78-86.
47. Puppo C, Mabire X, Cotte L, Castro DR, Spire B, Cua E, et al. Community-Based Care in the ANRS-IPERGAY Trial: The Challenges of Combination Prevention. AIDS Educ Prev. 2019 Jun;31(3):259-272.
48. Stekler JD, McMahan V, Ballinger L, Viquez L, Swanson F, Stockton J, et al. HIV Pre-exposure
Prophylaxis Prescribing Through Telehealth. J Acquir Immune Defic Syndr. 2018;77(5):e40-e42.
49. Phanuphak N, Sungsing T, Jantarapakde J, Pengnonyang S, Trachunthong D, Mingkwanrungruang P, et al. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. Sex Health. 2018 Nov;15(6):542-555.
50. Hood JE, Eljallad T, Abad J, Connolly M, Heumann C, Fritz J, et al. Getting pre-exposure prophylaxis to high-risk transgender women: lessons from Detroit, USA. Sex Health. 2018 Nov;15(6):562-569.
51. Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA, et al. HIV pre-
exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results
from a prospective observational demonstration project. PLoS Med. 2017 Nov;14(11):e1002444.
52. Ortblad KF, Kearney JE, Mugwanya K, Irungu EM, Haberer JE, Barnabas RV, et al. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya. Trials. 2019 Jul 4;20(1):396.
53. Pintye J, Kinuthia J, Roberts A, Wagner AD, Mugwanya K, Abuna F, et al. Integration of PrEP
Services Into Routine Antenatal and Postnatal Care: Experiences From an Implementation Program in
Western Kenya. J Acquir Immune Defic Syndr. 2018;79(5):590-595.
54. Roesch A. Implementing Pre-exposure Prophylaxis for HIV Prevention at an Urban Youth Clinic. J Assoc Nurses AIDS Care. 2019 Mar-Apr;30(2):232-237.
55. Hillis A, Germain J, Hope V, McVeigh J, Van Hout MC. Pre-exposure Prophylaxis (PrEP) for HIV
prevention among men who have sex with men (MSM): a scoping review on PrEP service delivery and
programming. AIDS Behav. 2020
56. Grimsrud A, Bygrave H, Doherty M, Ehrenkranz P, Ellman T, Ferris R, et al. Reimagining HIV
service delivery: the role of differentiated care from prevention to suppression. Journal of the International
AIDS Society. 2016;19(1):21484.
57. International AIDS Society. Differentiated Service Delivery: A Decision Framework for Differentiated Antiretroviral Therapy for Key Populations. IAS. 2018. https://www.iasociety.org/Differentiated-Service-Delivery. Accessed 28 March 2020.
58. Duncombe C, Rosenblum S, Hellmann N, Holmes C, Wilkinson L, Biot M, et al. Reframing HIV care: putting people at the centre of antiretroviral delivery. Tropical Medicine & International Health. 2015;20(4):430-447.
59. Mayer KH, Chan PA, Patel RR, Flash CA, Krakower DS. Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States. J Acquir Immune Defic Syndr. 2018;77(2):119-127.
60. Krakower DS, Mayer KH. The role of healthcare providers in the roll out of preexposure
prophylaxis. Curr Opin HIV AIDS. 2016 Jan;11(1):41-8.
61. AVAC: National Policies and Guidelines for PrEP - PrEP Watch. https://www.prepwatch.org/prep-planning/national-policies-guidelines/. Accessed 8 Nov 2019.
62. O'Malley G, Barnabee G, Mugwanya K. Scaling-up PrEP Delivery in Sub-Saharan Africa: What
Can We Learn from the Scale-up of ART? Curr HIV/AIDS Rep. 2019 Apr;16(2):141-150.
63. Mayer K, Appelbaum J, Rogers T, Lo W, Bradford J, Boswell S. The evolution of the Fenway Community Health model. American Journal of Public Health. 2001;91(6):892-894.
64. Mwai GW, Mburu G, Torpey K, Frost P, Ford N, Seeley J. Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review. Journal of the International AIDS Society. 2013;16(1):18586.
65. Wongkanya R, Pankam T, Wolf S, Pattanachaiwit S, Jantarapakde J, Pengnongyang S, et al. HIV rapid diagnostic testing by lay providers in a key population-led health service programme in Thailand. J Virus Erad. 2018;4(1):12-15.
66. Pérez-Figueroa RE, Kapadia F, Barton SC, Eddy JA, Halkitis PN. Acceptability of PrEP Uptake
Among Racially/Ethnically Diverse Young Men Who Have Sex With Men: The P18 Study. AIDS
education and prevention 2015;27(2):112-125.
67. Siegler AJ, Bratcher A, Weiss KM, Mouhanna F, Ahlschlager L, Sullivan PS. Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States. Annals of Epidemiology. 2018;28(12):858-864.
68. Estem KS, Catania J, Klausner JD. HIV Self-Testing: a Review of Current Implementation and
Fidelity. Current HIV/AIDS Reports. 2016;13(2):107-115.
69. Zucker J, Carnevale C, Rai AJ, Gordon P, Sobieszczyk ME. Positive or Not, That Is the Question:
HIV Testing for Individuals on Pre-exposure Prophylaxis. J Acquir Immune Defic Syndr. 2018;78(2):e11-
70. Vanden Berghe W, Nöstlinger C, Laga M. Syndemic and other risk factors for unprotected anal
intercourse among an online sample of Belgian HIV negative men who have sex with men. AIDS Behav.
71. Nöstlinger C, Reyniers T, Smekens T, Apers H, Laga M, Wouters K, et al. Drug use, depression
and sexual risk behaviour: a syndemic among early pre-exposure prophylaxis (PrEP) adopters in Belgium?
72. Ahmed K, Baeten JM, Beksinska M, Bekker L-G, Bukusi EA, Donnell D, et al. HIV incidence
among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a
levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. The Lancet.